M. Uzun Et Al. , "Does immunohistochemical marker conversion affect the prognosis in breast cancer patients receiving neoadjuvant chemotherapy?," Scientific reports , vol.14, no.1, pp.14651, 2024
Uzun, M. Et Al. 2024. Does immunohistochemical marker conversion affect the prognosis in breast cancer patients receiving neoadjuvant chemotherapy?. Scientific reports , vol.14, no.1 , 14651.
Uzun, M., Atag, E., Caliskan Yildirim, E., Keser, M., Semiz, H. S., & Unal, O. U., (2024). Does immunohistochemical marker conversion affect the prognosis in breast cancer patients receiving neoadjuvant chemotherapy?. Scientific reports , vol.14, no.1, 14651.
Uzun, Mehmet Et Al. "Does immunohistochemical marker conversion affect the prognosis in breast cancer patients receiving neoadjuvant chemotherapy?," Scientific reports , vol.14, no.1, 14651, 2024
Uzun, Mehmet Et Al. "Does immunohistochemical marker conversion affect the prognosis in breast cancer patients receiving neoadjuvant chemotherapy?." Scientific reports , vol.14, no.1, pp.14651, 2024
Uzun, M. Et Al. (2024) . "Does immunohistochemical marker conversion affect the prognosis in breast cancer patients receiving neoadjuvant chemotherapy?." Scientific reports , vol.14, no.1, p.14651.
@article{article, author={Mehmet Uzun Et Al. }, title={Does immunohistochemical marker conversion affect the prognosis in breast cancer patients receiving neoadjuvant chemotherapy?}, journal={Scientific reports}, year=2024, pages={14651} }